AXIS 2: AX200 for the Treatment of Ischemic Stroke
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of AX200 (filgrastim) in the treatment of
acute ischemic stroke and to assess the safety and tolerability of AX200.